Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to UAA200610876ApriorityCriticalpatent/UA83904C2/en
Publication of UA83904C2publicationCriticalpatent/UA83904C2/en
Investigating Or Analysing Biological Materials
(AREA)
Abstract
The invention relates to area of experimental medicine and veterinary and deals with modeling drug-induced gastro-enteritis with ulcer-erosion process in rats. To form model, one uses solution of diclophenac that is is given orally one time per day during 14 days, in doses 3.5-4.5 mg/kg of body mass (severe form of course of disease) or 2.5-3.5 mg/kg of body mass (medium severity of course of disease).
UAA200610876A2006-10-162006-10-16Method for modeling drug-induced gastro-enteritis with ulcer-erosion process in laboratory rats
UA83904C2
(en)
Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
Process for producing high purity safinamide or ralfinamide, use thereof in the preparation of medicaments and pharmaceutical formulations containing them
Malonamide derived compounds, gamma-secretase inhibitors; Preparation process; pharmaceutical composition; and its use in the treatment of Alzheimer's disease.